Waveform analysis of non-oscillatory independent components in single-trial auditory event-related activity in healthy subjects and Alzheimer's disease patients
Zervakis Michalis, B.W. Jervis, S. Belal, M. Besleaga, K .Michalopoulos, S. Fabri
Το work with title Waveform analysis of non-oscillatory independent components in single-trial auditory event-related activity in healthy subjects and Alzheimer's disease patients by Zervakis Michalis, B.W. Jervis, S. Belal, M. Besleaga, K .Michalopoulos, S. Fabri is licensed under Creative Commons Attribution 4.0 International
Bibliographic Citation
B.W. Jervis, S. Belal, T. Cassar, M. Besleaga, C. Bigan, K. Michalopoulos, M. Zervakis, K. Camilleri, S. Fabri ," Waveform analysis of non-oscillatory independent components in single-trial auditory event-related activity in healthy subjects and Alzheimer's disease patients,"Cur. Alzheimer Res., vol.7,no.4, pp.334-347,2010. doi:10.2174/156720510791162412
https://doi.org/10.2174/156720510791162412
The objective was to characterize the non-oscillatory independent components (ICs) of the auditory event-related potential (ERP) waveform of an oddball task for normal and newly diagnosed Alzheimer's disease (AD) subjects, and to seek biomarkers for AD. Single trial ERP waveforms were analysed using independent components analysis (ICA) and k-means clustering. Two stages of clustering depended upon the magnitudes and latencies, and the scalp topographies of the non-oscillatory back-projected ICs (BICs) at electrode Cz. The electrical current dipole sources of the BICs were located using Low Resolution Electromagnetic Tomography (LORETA). Generally 3-10 BICs, of different latencies and polarities, occurred in each trial. Each peak was associated with positive and negative BICs. The trial-to-trial variations in their relative numbers and magnitudes may explain the variations in the averaged ERP reported, and the delay in the averaged P300 for AD patients. The BIC latencies, topographies and electrical current density maximum locations varied from trial-to-trial. Voltage foci in the BIC topographies identify the BIC source locations. Since statistical differences were found between the BICs in healthy and AD subjects, the method might provide reliable biomarkers for AD, if these findings are reproduced in a larger study, independently of other factors influencing the comparison of the two populations. The method can extract artefact- and EEG-free single trial ERP waveforms, offers improved ERP averages by selecting the trials on the basis of their BICs, and is applicable to other evoked potentials, conditions and diseases.